Jefferies downgraded Healthcare Realty Trust (HR) to Hold from Buy with a price target of $17, down from $19. The company is entering 2025 with a leadership change, limited external growth potential, and elevated dividend cut risk, the analyst tells investors in a research note. The firm says Healthcare Realty dismissed its former CEO in November and messaged that it would take 6-9 months to appoint a new, permanent CEO. This comes as the company is unable to grow externally given its high leverage and cost of equity, and with a dividend that may take multiple quarters to cover, contends Jefferies. As such, it sees “a lot of uncertainty.”
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HR:
- Healthcare Realty Trust downgraded to Neutral from Overweight at JPMorgan
- Healthcare Realty Trust price target raised to $17 from $16 at Wells Fargo
- Healthcare Realty Trust announces CFO, general counsel changes
- Healthcare Realty Trust Announces Key Leadership Changes
- Healthcare Realty Trust Revamps Board for Strategic Growth